Conivaptan Completed Phase 2 Trials for Chronic Heart Failure (CHF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00057356Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure